Perigon Wealth Management’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $542K | Hold |
146,133
| – | – | 0.01% | 646 |
|
|
2025
Q1 | $472K | Hold |
146,133
| – | – | 0.01% | 655 |
|
|
2024
Q4 | $684K | Sell |
146,133
-37
| -0% | -$173 | 0.02% | 549 |
|
|
2024
Q3 | $1.58M | Hold |
146,170
| – | – | 0.04% | 322 |
|
|
2024
Q2 | $3.07M | Buy |
146,170
+20
| +0% | +$420 | 0.09% | 199 |
|
|
2024
Q1 | $4.66M | Sell |
146,150
-100,000
| -41% | -$3.19M | 0.14% | 151 |
|
|
2023
Q4 | $4.99M | Hold |
246,150
| – | – | 0.16% | 130 |
|
|
2023
Q3 | $3.13M | Buy |
246,150
+75
| +0% | +$955 | 0.13% | 157 |
|
|
2023
Q2 | $4.45M | Hold |
246,075
| – | – | 0.17% | 126 |
|
|
2023
Q1 | $4.23M | Hold |
246,075
| – | – | 0.24% | 94 |
|
|
2022
Q4 | $5.47M | Sell |
246,075
-4,400
| -2% | -$97.7K | 0.34% | 72 |
|
|
2022
Q3 | $2.01M | Sell |
250,475
-98,271
| -28% | -$790K | 0.17% | 121 |
|
|
2022
Q2 | $2.43M | Sell |
348,746
-208,729
| -37% | -$1.46M | 0.2% | 104 |
|
|
2022
Q1 | $8.43M | Sell |
557,475
-209,492
| -27% | -$3.17M | 0.6% | 30 |
|
|
2021
Q4 | $16.8M | Buy |
+766,967
| New | +$16.8M | 1.2% | 13 |
|